GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Cash Flow for Lease Financing

AFT Pharmaceuticals (ASX:AFP) Cash Flow for Lease Financing : A$0.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Cash Flow for Lease Financing?

AFT Pharmaceuticals's Cash Flow for Lease Financing for the six months ended in Sep. 2023 was A$0.0 Mil. AFT Pharmaceuticals's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2023 was A$0.0 Mil.

Compared with last quarter (A$0.0 Mil in Mar. 2023 ), AFT Pharmaceuticals's Cash Flow for Lease Financing remained the same in Sep. 2023 (A$0.0 Mil).

AFT Pharmaceuticals Cash Flow for Lease Financing Historical Data

The historical data trend for AFT Pharmaceuticals's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Cash Flow for Lease Financing Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

AFT Pharmaceuticals Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AFT Pharmaceuticals Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFT Pharmaceuticals Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (ASX:AFP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Cash Flow for Lease Financing
Comparable Companies
NZSE:CBD NZSE:RUA NZSE:GFI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 VTRS NBIX SZSE:000963 SHSE:600085 XPAR:IPN
Traded in Other Exchanges
AFT:New Zealand
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
Website
https://www.aftpharm.com
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines